A simple, fast and cost-effective liquid chromatographic/tandem mass spectrometry (LC-MS-MS) method for the quantitative determination of flunixin (FLU) in bovine muscle was developed and validated. The sample preparation procedure involved an extraction with acetonitrile, followed by evaporation and reconstitution. Chromatographic separation was achieved on a reverse-phase column under programmed conditions. FLU detection was performed with positive electrospray ionization in selected reaction monitoringmode, monitoring one precursor and two products ions. For quantification purposes, FLU-d3 was used as an internal standard. The matrix effect on the analysis of FLU in bovine muscle was evaluated by comparison between calibration curves prepared with standard solution and in blank matrix extracts. The equivalent responses obtained confirmed the absence of signal suppression or/and enhancement. The method was extensively validated according to the parameters requested by European Commission Decision 2002/657/EC in terms of specificity, limit of detection, linearity, trueness, precision, decision limit (CCa) and detection capability (CCb). FLU stability was also investigated in matrix and in sample extracts at different times and storage conditions.
Introduction
Flunixin (FLU) is a non-steroidal anti-inflammatory drug (NSAID) that shows non-narcotic analgesic and antipyretic properties. It is widely used in veterinary medicine for the treatment of various diseases in several animal species. It can be employed in order to reduce inflammation and pain associated with musculoskeletal disorder or colic in horses, in the treatment of mastitis-metritisagalactia syndrome in sows and as an aid in the cure of pulmonary diseases and endotoxin-induced mastitis in cattle (1, 2) .
The major effect of FLU, as all the NSAID, is the reversible inhibition of the cyclooxygenase, an enzyme that catalyzes the formation of prostaglandins through the arachidonic acid cascade. Side effects associated with the use of NSAID have been reported especially after acute overdose, prolonged treatments or combined use of several NSAIDs. The main adverse effects reported are gastrointestinal erosion and ulceration, renal vasoconstriction and insufficiency, skin reaction, headache and central nervous system depression (3, 4) .
Owing to these aspects, the European Union (EU) has set maximum residue limits (MRLs) for FLU in edible tissues and in milk. In particular, the MRL in bovine muscle is 20 mg kg 21 (5) . Several analytical methods have been already published for the analysis of this NSAID in biological matrices. Earlier works were based on liquid chromatography separation followed by UV or DAD detection, while more recently liquid or gas chromatography coupled with mass spectrometry has become the most common detection technique.
Most of the published LC-MS protocols are specific for the determination of FLU in biological matrices, such as plasma (6) (7) (8) (9) (10) , urine (11 -13) or milk (3, 10, 14 -19) , while few are available for edible tissues (3, 4, 20 -24) .
Concerning the residues of this drugs in muscle, the existing procedures were based on time-consuming extraction and purification techniques, such as enzymatic or acid hydrolysis of the tissue (20, 22, 23) and clean-up of the extract on SPE cartridges (3, 4, 20, 21, 23) .
The aim of this work was to develop a simple, fast and cheap method for the quantitative determination of FLU in bovine muscle by LC-MS-MS. The proposed method, although based on an easy sample extraction, showed excellent performances, proving to be reliable and efficient according to the validation parameters requested by the current European regulations (25).
Materials and methods

Materials and reagents
Standard reference materials of FLU meglumine and FLU-d3, used as internal standard (IS), were purchased from Sigma-Aldrich (St. Louis, MI, USA).
Acetonitrile and formic acid were of LC -MS grade and were obtained from Riedel-de Hae¨n (Seelze, Germany), while ultrapure water was produced in-house by a Human Power w I apparatus from Human Corporation (Seoul, Korea).
Acetonitrile, used as extraction solvent, was of analytical grade and purchased from Merck (Darmstadt, Germany).
Preparation of standard solutions
Standard stock solution of FLU was prepared at a concentration of 500 mg mL 21 (corrected for purity and for the meglumine salt) by dissolving the pure substance in a volumetric flask with a CH 3 Stock solution of FLU-d3 was prepared at a concentration of 100 mg mL 21 by dissolving the pure substances in acetonitrile, and the IS working solution (0.4 mg mL
21
) was obtained by appropriate dilution of stock solution in acetonitrile.
All the standard solutions were stored at 2208C in darkness until use and were stable up to 1 month.
The working solutions were divided into small aliquots (about 2 mL) and after each analysis day, the employed portion was discarded.
Tuning standard solutions of FLU and FLU-d3, at a concentration of 1 mg mL
, were prepared by dilution in 0.1% formic acid H 2 O : CH 3 CN (90 : 10, v : v).
Equipment
The liquid chromatography device was an Alliance 2695 system consisting of a quaternary pump, solvent degasser, autosampler and column heater from Waters Corporation (Milford, MA, USA). Separation was performed on an XBridge TM C18 Waters column (3.5 mm, 2.1 Â 150 mm) fitted with a guard column of the same type (3.5 mm, 2.1 Â 10 mm) (Waters Corporation).
The mass spectrometer was a Quattro Premier XE triple quadrupole instrument equipped with an ESCI TM Multi-Mode Ionization Source (Waters Corporation).
High-purity nitrogen was produced by nitrogen gas generator Mistral-4 from DBS Instrument (Padua, Italy).
Data acquisition and processing were performed using the Mass Lynx 4.1 software (Waters Corporation).
Samples and pretreatment
The matrix used for validation consisted of 21 bovine muscle samples (10 + 0.4 g) purchased from a retail market. Preliminary analyses showed that the individual muscle tissues were analyte free. Tissues were homogenized for 2-3 min at 28,000 rpm using an IKA A11 basic analytical mill (Staufen, Germany) at room temperature. Aliquots of 200 + 12 mg of homogenized muscle were transferred into individual 10 mL plastic tubes and stored at 2208C until being thawed for analysis. Each sample was also added 20 mL of IS working solution, corresponding to a concentration of 40 mg kg 21 of FLU-d3. After adding the FLU working solutions, the samples were mixed using a Vortex Wizard (Velp Scientifica, Milano, Italy) for 15 s and then kept at room temperature for 10 min before undergoing the extraction procedure.
Sample preparation procedure Bovine muscle tissue samples, pretreated as described in the section Samples and pretreatment, were defrosted at room temperature. As previously described for calibrations curve and QC samples, 20 mL of FLU-d3 IS working solution was then added to each sample. After vortex-mixing for 15 s, 1500 mL of acetonitrile was added. The sample was homogenized with an Ultra-Turrax, T25 digital IKA (Staufen, Germany), at 24,000 rpm for 2 min. The homogenized sample was sonicated for 5 min in a Branson 2510 ultrasonic bath (Danbury, Connecticut, USA) and then centrifuged at 4,000 Â g for 5 min at 48C in a Hettich 320 R centrifuge (Beverly, Massachusetts, USA). A volume of 1000 mL of supernatant was transferred into a 1.5 mL Eppendorf tube and evaporated to dryness in a Genevac MiVac Duo vacuum concentrator centrifuge (Ipswich, UK).
The evaporated extract was reconstituted in 150 mL of a 0.1% formic acid in H 2 O : CH 3 CN (50 : 50, v : v) solution and then 10 mL was injected into the LC-MS-MS system.
LC-MS-MS conditions
Chromatographic separation was achieved using reverse-phase chromatography with gradient elution. Mobile Phase A was 0.1% formic acid in water and mobile Phase B was 0.1% formic acid in acetonitrile.
The following gradient program (time, % A -% B) was applied: (0.00 min, 50 -50), (0.20 min, 50 -50), (2.00 min, 10 -90), (7.00 min, 10 -90) and (9.00 min, 50-50). The column was allowed to equilibrate at the initial conditions for 6 min between each sample injection. The flow rate was 0.2 mL/min and the column temperature was maintained at 358C. The solvent front was diverted to waste between 0 and 3 min, and after this period the flow was directed to the ionization source.
The mass spectrometer interface was an electrospray ionization source operating in the positive ion mode (electrospray interface, ESIþ) at the following conditions: capillary voltage, 3.50 kV; source temperature, 1208C; desolvation temperature, 3008C; desolvation and cone gas (nitrogen) flow, 700 and 90 L/h, respectively.
Mass spectrometry analyses were performed in the selected reaction monitoring mode, monitoring two specific transitions for each compound. Argon was used as collision gas for collision-induced dissociation. The analyte-dependent MS-MS parameters were optimized via direct infusion of tuning standard solution into the mass spectrometer. The optimal values of cone voltage, collision energy and the two main transitions for each compound are given in Table I .
Method validation
The proposed LC-MS-MS method for FLU quantification in bovine muscle tissue was validated in-house according to the main requirements of European Commission Decision 2002/ 657/EC (25). The following parameters were evaluated: specificity, limit of detection (LOD), linearity, trueness, precision, decision limit (CCa) and detection capability (CCb).
The specificity was evaluated by checking the ion chromatograms of 21 blank samples extracted and analyzed with the above-mentioned method for potential co-eluting interfering compounds, which can impair interpretation at the specific retention time of the analytes. The 21 blank samples used for specificity evaluation were also used to calculate LOD. The analytical background at the retention time of FLU in all blank samples was recorded, and the apparent concentrations of FLU were measured. The LOD was then calculated using the following equation: LOD ¼ X þ 3s, where X is the mean apparent concentration of FLU and s is the standard deviation (26) .
The linearity of the method was assessed with calibration curves freshly prepared each analysis day. The calibration curves were obtained spiking blank tissue samples with FLU at the following concentrations: 0, 10, 15, 20, 30 and 40 mg kg 21 (for more details, see section Preparation of calibration curve and quality control samples.). Peak area ratios between the FLU and the IS were plotted against their concentration ratios, and a linear regression model was applied.
To check the validity of the regression model, the analysis of variance (ANOVA) and an F-test were performed, while the linearity of the analytical response was investigated by using the lack-of-fit test (LOF) (27) .
Since no Certified Reference Material was available, trueness and precision were determined by analyzing blank samples fortified (QC samples) at three different concentrations (0.5Â MRL, MRL and 2.0Â MRL). In particular, 18 spiked samples for each level were processed individually on three different days (six samples per day). The choice of using a concentration of 2.0Â MRL for the highest QC (instead of 1.5Â MRL as requested by Commission Decision 657/2002/CE) was made in order to be compliant also with the requirements expressed by EudraLex, which sets the rules regulating medicinal products in the EU (28) .
Stability experiments FLU stability in matrix was investigated: different storage conditions were tested in order to simulate real conditions, which samples could undergo in a laboratory before analysis. This was necessary for the determination how long samples can be stored under the proposed storage conditions without significant degradation. FLU stability in matrix was determined using groups of six QC samples fortified at the MRL (20 mg kg 21 ). In particular, short-term (or bench-top) stability was evaluated by analyzing samples stored at room temperature for 6 h. Stability at 2208C for 19 days was also tested. The freeze/thaw stability was assessed after three freeze/thaw cycles (during each cycle, samples were maintained for at least 24 h at 2208C and then thawed for 2-3 h before been refrozen).
Post-preparative stability was assessed by analyzing extracts of QC samples at the MRL after 7 days of storage at 2208C and after 4 days of storage in the autosampler at room temperature.
The results obtained from the analysis of the QC samples stored under the described conditions were compared with those obtained from a set of six QCs freshly prepared and coefficient of variation (CV %) was measured.
Matrix effect
Some experiments were conducted to evaluate the matrix effect, which can greatly affect the analyte response in biological matrices.
Six-point standard and matrix-matched calibration curves were compared, and a t-test was applied to statistically quantify the slope difference between them. The standard calibration curve was prepared in water at different FLU concentrations (0, 10, 15, 20, 30 and 40 ng mL 21 ), while a pool of blank bovine muscle samples was used to prepare the correspondent matrix-matched calibration curve. A fixed amount of IS working solution (40 ng mL 21 ) was added to each standard and matrix-matched solution.
The t-value was calculated using the following formula described by Soliani (29) :
where n24 are the degrees of freedom; b1 and b2, the slopes of the two calibration curves to be compared and es (b1 2 b2) , the standard error of the difference between the two slopes.
Results and discussion
Optimization of the sample preparation procedure While developing the proposed method, special attention was paid to optimization of the sample preparation procedure. Different combinations of extraction and clean-up techniques (ultrasonication, homogenization and SPE) were tested.
Methanol and acetonitrile were initially compared as extraction solvents and the second resulted to be more efficient for the extraction of the target compound from muscle tissue, allowing a more effective protein precipitation. Moreover, the extraction capability of acetonitrile was further enhanced by an ultrasonication step.
The addition of a clean-up with Oasis w HLB cartridges (Waters Corporation) after sample extraction was also tested, in order to try to obtain an even cleaner extract and a higher analyte recovery. The acetonitrile extract was evaporated to dryness, reconstituted in water : methanol 90 : 10 (v/v) and loaded. The SPE cartridge was then washed with water : methanol 95 : 5 (v/v) and eluted with methanol followed by 10% acetic acid in n-hexane (18) . The LC-MS-MS analysis of the dried and reconstituted eluate showed a significantly lower response compared with samples which did not undergo SPE clean-up, probably due to a loss of the analyte during loading/washing or to its incomplete elution. For this reason, it was decided that the SPE purification step be skipped, with a significant reduction in terms of costs and time required for the analyis.
The use of an IS improves the accuracy and reproducibility of the method, since it can compensate for potential variations in extract volume, sample losses and mass spectrometric response, caused by suppression or enhancement of the matrix effect. Stable isotope analogs are the best choice when available; otherwise, isomers or homologs of the analyte can also be employed as IS. In this study, deuterated FLU (d3) was used, contributing to the achievement of very good analytical performances.
Analytical performances
Different chromatographic conditions were tested to obtain an optimal retention and a good separation of the analytes from the matrix interfering compounds in a reasonable analysis time. The chosen chromatographic gradient allowed a good elution of the analytes in 5.8 min, with better-shaped and more symmetrical peaks. After the end of the chromatographic run, the column was equilibrated to the initial conditions for at least 6 min in order to obtain a good reproducibility of the retention times.
The use of a divert valve ensured that early eluting matrix compounds were discarded into the waste, thereby reducing contamination of the ion source and allowing a large number of samples to be analyzed without having to clean the source components.
The mass spectra of FLU and FLU-d3 were acquired after direct infusion of the tuning standard solutions. For both analytes, the higher response was obtained using an ESI operating in positive ionization.
Both compounds were identified on the basis of retention time, the presence of two specific mass transitions for each compound and ion ratio of these product ions. This fulfilled the identification criteria established by Commission Decision 2002/ 657/EC (25): even though a minimum of three identification points are required for the confirmation of substances listed in the Group B of Annex I of Council Directive 96/23/EC (30), four identification points were gained by measuring two product ions in addition to the precursor ion. Moreover, the ion ratios observed in the samples matched that of the standards. The relative intensity of the two monitored transitions, expressed as a percentage of the intensity of the most intense transition, corresponded to the mean ion ratio of the calibration standards, within the maximum permitted tolerance (for ion ratio of .0.50, the maximum permitted tolerance is +20%).
Method validation
The specificity of the method was demonstrated by the absence of endogenous interferences at the specific retention time of FLU and FLU-d3. Figure 1 shows typical chromatograms of a blank muscle sample and of a muscle sample spiked with FLU at the MRL level (20 mg kg
21
) and FLU-d3 at 40 mg kg
. The 21 blank samples used for the evaluation of the specificity were in compliance with the minimum number of six separate sources stated in the EMA guideline VICH GL49 (26) .
The apparent concentration of FLU was determined in each blank samples, and the calculated LOD was 0.02 mg kg
. A six-point calibration curve was injected twice during each day of analysis (at the beginning and end of the batch), in order to assess potential response variations that could affect samples quantification.
Each daily calibration curve was accepted when the accuracy value of 75% of calibration samples fell within +15% the nominal value (except for the lower limit of quantification of the curve, for which the acceptance range was +20% the nominal value) (26) .
The regression lines obtained were all satisfactory, with a coefficient of determination (r 2 ) always higher than 0.9565. F REG , calculated on the 3 different days of validation, was always consistently higher than the tabulated value of 4.96 (a ¼ 0.05; df1 ¼ 1; df2 ¼ 10), proving that the chosen model of regression was valid; F LOF did not exceed the reported value of 4.53 (a ¼ 0.05; df1 ¼ 4; df2 ¼ 6), confirming the linearity of the calibration curves.
Trueness was expressed as bias, that is the relative difference between the mean measured value and the spiked concentration and for the considered concentrations had to be between 220 and þ10%, according to the Commission Decision 657/2002/EC (25).
Precision was measured as relative standard deviation to the mean (CV %). Values of CV % in within-laboratory reproducibility conditions (samples analyzed by different operators on different days) had to be lower than the value calculated according to the Horwitz equation: CV % ¼ 2 (120.5Âlog c) , where c is the concentration of analyte expressed as a decimal fraction. In repeatability conditions (intra-day analysis), CV % values had to be lower than two-thirds of the values calculated according to the Horwitz equation.
The results of the trueness and precision experiment, summarized in Table II, , respectively. These maximum allowed CV % values were respected in all cases, as presented in Table II . Moreover, testing concentrations in the range from 0.5Â MRL to 2.0Â MRL (as detailed in section Method validation) allowed to assess method's accuracy over an even wider range than requested by Commission Decision 657/2002/CE, making it compliant also with the requirements for residue depletion studies (28) .
CCa and CCb were determined as described in Commission Decision 657/2002/EC (25).
CCa is defined as the concentration level above which a sample can be declared non-compliant with an error probability equal to a (¼5%), whereas CCb is defined as the concentration limit at which the method is able to detect permitted limit concentrations with a statistical certainty of 1 2 b (b ¼ 5%). CCa and CCb were calculated following the calibration curve procedure described in the Commission Decision 657/2002/EC (23) . Blank samples, fortified for trueness and precision experiment at 0.5Â MRL, MRL and 2.0Â MRL levels (n ¼ 18), were used to obtain a calibration curve, and then CCa and CCb were calculated in accordance with ISO standard 11843-2 (31).
Verdon et al. (32) described this procedure for calculating CCa and CCb, both for non-permitted substances and for substances with MRL. According to their equations, the CCa and CCb values of the present method were 22.85 and 27.28 mg kg
, respectively.
Stability experiment
The stability of FLU in matrix was investigated using QC samples fortified at MRL and stored at different conditions before sample analysis.
The post-preparative stability of FLU in sample extracts was assessed by re-analyzing the extracts of QC samples at the MRL after storage at different conditions. Stability was considered acceptable if the mean concentration obtained from the analysis of these QC stability experiments, samples agreed with the freshly prepared QC samples within +15% (33) . With the exception of post-preparative stability at room temperature, almost all the results fulfilled this requirement, being included in the range between 1.0 and 10.5%.
In the tested conditions, FLU proved to be stable in bovine muscle for at least 19 days in samples stored at 2208C and for 6 h in samples stored at room temperature. Moreover, stability in matrix was assessed after three freeze/thaw cycles.
Concerning the post-preparative stability, FLU proved to be stable in sample extracts stored for at least 7 days at 2208C, while it was not stable after 4 days at room temperature (CV % ¼ 28.5%). This might be due to a concentration of the sample extract consequent to acetonitrile evaporation at room temperature. However, it must be noted that, in usual laboratory conditions, a post-preparative stability of 24-48 h is sufficient to fully cover an analytical sessions, including potentially needed reinjections, and therefore, a shorter period might be tested.
Matrix effect
The effect of matrix on the determination of FLU in bovine muscle was evaluated comparing the matrix-matched calibration curve with the standard solution calibration curve. The equation of the matrix-matched curve was: y ¼ 4.17 Â 10
22 Â x þ 2.26 Â 10
22
, while the standard solution curve showed the following equation: y ¼ 3.99 Â 10
22 Â x þ 3.65 Â 10
. The absence of a significant difference between the slopes of the two calibration curves was also confirmed by the t-test. With a significance alpha level of 0.05 and eight degrees of freedom, the critical t-value is 2.306, and for t-values higher than 2.306, the slope difference is considered statistically significant, meaning that the matrix effect is present. In the present case, the t-value, calculated according to Soliani (29) was 1.287, and hence, no matrix effect was observed.
Conclusions
An LC-MS-MS method for the quantitative determination of FLU in bovine muscle was successfully developed and validated. FLU-d3 was used as labeled IS, assuring a reliable quantification of the analyte. The method provided excellent performances and fulfilled the current European guidelines requirements on analytical method validation.
The sample extraction, based on a liquid/solid extraction with acetonitrile, allowed to reduce ,15 min the time required to prepare sample extracts, which proved to be free from signal enhancement or suppression due to matrix effect. This easy and quick preparation procedure provides high sample throughput, a useful tool for an effective, sensitive and selective FLU quantification in bovine muscle that can be employed also for residue depletion studies. 
